Page 220 Acute Pain Management
P. 220

 




Cost of PCA
The
use
of
any
analgesic
technique,
even
if
it
is
known
to
provide
more
effective
pain
relief,

also
requires
consideration
of
the
cost
involved.
There
are
no
good,
consistent
data
on
the

cost‐effectiveness
of
PCA
compared
with
conventional
opioid
analgesic
techniques;

information
that
is
available
often
does
not
include
the
full
scope
of
costs
(eg
cost
of
adverse

events
or
failure
of
an
analgesic
technique
as
well
as
the
more
obvious
costs
of
pumps,

disposables
and
nursing
time).
However,
in
general,
PCA
comes
at
a
higher
cost
because
of

the
equipment,
consumables
and
drugs
required;
nursing
time
needed
is
much
less
(Jacox
et
al,

1997;
Choiniere
et
al,
1998
Level
II;
Rittenhouse
&
Choiniere,
1999;
Chang
et
al,
2004
Level
II).
PCA
was

more
cost‐effective
than
epidural
analgesia
after
major
abdominal
surgery
(Bartha
et
al,
2006).


7.1.2 Drugs used for parenteral PCA

Opioids
In
general
there
is
little
evidence,
on
a
population
basis,
to
suggest
that
there
are
any
major

differences
in
efficacy
or
the
incidence
of
side
effects
between
morphine
and
other
opioids

commonly
used
in
PCA,
although
the
results
of
individual
studies
are
inconsistent.

Pethidine

Compared
with
morphine,
pethidine
(meperidine)
may
lead
to
less
effective
pain
relief
on

movement
(Bahar
et
al,
1985
Level
II;
Sinatra
et
al,
1989
Level
II;
Plummer
et
al,
1997
Level
II);

no
difference
in
nausea
and
vomiting
(Bahar
et
al,
1985
Level
II;
Stanley
et
al,
1996
Level
II;

Woodhouse
et
al,
1996
Level
II;
Plummer
et
al,
1997
Level
II);
and
less
sedation
(Sinatra
et
al,

1989
Level
II)
and
pruritus
(Sinatra
et
al,
1989
Level
II;
Woodhouse
et
al,
1996
Level
II).


Fentanyl

There
was
no
difference
between
morphine
and
fentanyl
in
terms
of
pain
relief
(Howell
et
al,

CHAPTER
7
 1995
Level
II;
Woodhouse
et
al,
1996
Level
II)
or
the
incidence
of
most
side
effects
(Howell
et
al,

1995
Level
II;
Woodhouse
et
al,
1996
Level
II);
pruritus
was
more
common
with
morphine

(Woodhouse
et
al,
1996
Level
II).



Tramadol

Tramadol
by
PCA
had
a
similar
analgesic
effect
compared
with
morphine
(Erolcay
&
Yuceyar,

2003
Level
II;
Unlugenc,
Vardar
et
al,
2008
Level
II),
pethidine
(Unlugenc,
Vardar
et
al,
2008
Level
II)

and
oxycodone
(Silvasti
et
al,
1999
Level
II).
The
majority
of
studies
showed
that
the
incidence

of
nausea
and
vomiting
was
no
higher
than
with
pure
agonist
opioids
(Silvasti
et
al,
1999
Level
II;

Erolcay
&
Yuceyar,
2003
Level
II;
Unlugenc,
Vardar
et
al,
2008
Level
II).
Tramadol
also
had
a
lower
risk

of
respiratory
depression
and
less
effect
on
gastrointestinal
motor
function
compared
with

other
opioids
(see
Section
4.1.2).

Other
comparisons

Other
comparisons
with
morphine
include
hydromorphone
(no
difference
in
pain
relief
or
side

effects)
(Rapp
et
al,
1996
Level
II;
Hong
et
al,
2008
Level
II),
oxycodone
(no
difference
in
pain
relief

or
side
effects)
(Silvasti
et
al,
1998
Level
II)
and
piritramide
(equally
effective
and
similar
side

effects)
(Dopfmer
et
al,
2001
Level
II).

Remifentanil
provided
at
least
equivalent
analgesia
compared
with
morphine
(Kucukemre
et
al,

2005
Level
II;
Gurbet
et
al,
2004
Level
II)
and
fentanyl
PCA
(Gurbet
et
al,
2004
Level
II)
and
may
be

associated
with
less
nausea
and
vomiting
(Kucukemre
et
al,
2005
Level
II;
Gurbet
et
al,
2004

Level
II).





172
 Acute
Pain
Management:
Scientific
Evidence

   215   216   217   218   219   220   221   222   223   224   225